| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |